Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations

[1] Karakucuk A(2019)Evaluation of improved oral bioavailability of ritonavir nanosuspension Eur J Pharm Sci 131 153-158

[2] Teksin ZS(2019)Optimization and Journal of Drug Delivery Science and Technology. 52 37-45

[3] Eroglu H(2005) evaluation of ziprasidone nanosuspensions produced by a top-down approach Drug Dev Ind Pharm 31 319-329

[4] Celebi N(2004)Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound Drug Dev Ind Pharm 30 233-245

[5] Tashan E(2013)Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs J Control Release 172 1126-1141

[6] Karakucuk A(2019)Stability of nanosuspensions in drug delivery Int J Pharm 566 67-76

[7] Celebi N(2017)Development of daidzein nanosuspensions: preparation, characterization, Eur J Pharm Sci 109 200-208

[8] Langguth P(2017) evaluation, and pharmacokinetic analysis Int J Pharm 531 246-256

[9] Hanafy A(2010)Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: physicochemical and pharmacokinetic investigation Eur J Pharm Sci 40 325-334

[10] Frenzel D(2019)Nanosuspensions of a new compound, ER-β005, for enhanced oral bioavailability and improved analgesic efficacy Materials. 12 3355-150

[1] Karakucuk A(2019)Evaluation of improved oral bioavailability of ritonavir nanosuspension Eur J Pharm Sci 131 153-158

[2] Teksin ZS(2019)Optimization and Journal of Drug Delivery Science and Technology. 52 37-45

[3] Eroglu H(2005) evaluation of ziprasidone nanosuspensions produced by a top-down approach Drug Dev Ind Pharm 31 319-329

[4] Celebi N(2004)Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound Drug Dev Ind Pharm 30 233-245

[5] Tashan E(2013)Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs J Control Release 172 1126-1141

[6] Karakucuk A(2019)Stability of nanosuspensions in drug delivery Int J Pharm 566 67-76

[7] Celebi N(2017)Development of daidzein nanosuspensions: preparation, characterization, Eur J Pharm Sci 109 200-208

[8] Langguth P(2017) evaluation, and pharmacokinetic analysis Int J Pharm 531 246-256

[9] Hanafy A(2010)Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: physicochemical and pharmacokinetic investigation Eur J Pharm Sci 40 325-334

[10] Frenzel D(2019)Nanosuspensions of a new compound, ER-β005, for enhanced oral bioavailability and improved analgesic efficacy Materials. 12 3355-150